Multidrug Resistance in Hepatocellular Carcinoma
Author:
Publisher
Codon Publications
Reference94 articles.
1. Hepatocellular Carcinoma: Etiology and Current and Future Drugs
2. Resistance a major hindrance to chemotherapy in hepatocellular carcinoma: an insight
3. Mechanisms of cancer: multidrug resistance
4. Different strategies to overcome multidrug resistance in cancer
5. Understanding of human ATP binding cassette superfamily and novel multidrug resistance modulators to overcome MDR
Cited by 10 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. pH-tailored delivery of a multitarget anticancer benzimidazole derivative using a PEGylated β-cyclodextrin-curcumin functionalized nanocomplex;Biomaterials Advances;2024-10
2. Computational-guided approach for identification of PI3K alpha inhibitor in the treatment of hepatocellular carcinoma by virtual screening and water map analysis;Journal of Biomolecular Structure and Dynamics;2024-01-10
3. The Role of Tumor Stem Cells in Colorectal Cancer Drug Resistance;Cancer Control;2024-01
4. XBP1 as a novel molecular target to attenuate drug resistance in hepatocellular carcinoma;Expert Opinion on Therapeutic Targets;2023-12-02
5. DOG1 as a novel antibody-drug conjugate target for the treatment of multiple gastrointestinal tumors and liver metastasis;Frontiers in Immunology;2023-01-26
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3